CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — InVivo Therapeutics Holdings Corp. (NVIV) on Wednesday reported a loss of $2.7 million in its third quarter.
The Cambridge, Massachusetts-based company said it had a loss of 87 cents per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NVIV at https://www.zacks.com/ap/NVIV
Advertisement